Global private equity and venture capital news and research

Posts Tagged ‘Ysios Capital’

8 September 2015

Ysios Capital leads €36.6m Series C for drug developer Sanifit

pills-530372_1280 Spanish early-stage investment firm Ysios Capital has led a €36.6m Series C investment round for clinical-stage biopharma business Laboratoris Sanifit.

23 April 2014

Kala Pharmaceuticals scores $22.5m Series B

dollar envelope money Ysios Capital has led a $22.5m Series B round for Kala Pharmaceuticals, which is focused on developing ophthalmic products based on its mucus penetrating particle technology.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015